Bracco Imaging reinforces its portfolio in Interventional Oncology
Summary
One of the key challenges clinicians have to face during interventional procedures is the precise introduction of a probe into a deep target within the body that is not visible.developed Endosight™ a high-end guidance system based on augmented reality and a sophisticated imaging software (Ablation-fit™) for 3D reconstruction, planning and diagnosis to be used in surgery during mini-invasive Percutaneous Tumor Ablation procedures in Computed Tomography-based Interventional Oncology.The solution has been developed to provide intuitive visualization with no need for manipulation or further interaction to ensure accurate targeting, without compromising workflow, procedure duration, or interventional outcomes."In preclinical studies, Endosight™ demonstrated unparalleled performances that make it possible to "see through" the patient without the need for direct imaging support, thanks to the augmented reality.The Company operates in more than 100 markets worldwide, either directly or indirectly, through subsidiaries, joint ventures, licenses and distribution partnership agreements.